Evidence map›Paper›PMID 41537764›Full record

ArticleMolecular biology of the cell2026

Wnt signaling is modulated by the buffer-like properties of cadherins.

Lauren Schnitkey, Christin Anthony, Marina Cardó-Vila, Matthew A Loberg, Gemma Orton, Allison McCabe, Jonathan Trapani, Mary Rockouski, Joyce Luo, Sheau-Chiann Chen and 7 more

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lauren SchnitkeyDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232.
Christin AnthonyDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232.
Marina Cardó-VilaDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85721.
Matthew A LobergDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232.
Gemma OrtonDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232.
Allison McCabeProgram in Cancer Biology, Vanderbilt University, Nashville, TN 37232.
Jonathan TrapaniDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232.
Mary RockouskiDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232.
Joyce LuoDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232.
Sheau-Chiann ChenDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232.
Fei YeDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232.
David J RobbinsDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057.
Yashi AhmedDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755.
Konstantin DoubrovinskiDepartment of Biophysics, UT Southwestern Medical Center, Dallas, TX 75390.
Vivian L WeissDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232.
Curtis A ThorneDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85721.
Ethan LeeDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232.ORCID 0000-0001-8405-6156

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Understanding the role of RNA-binding protein mutations in cancerP20GM113132 · NIGMS · DARTMOUTH COLLEGE · PI MADDEN, DEAN R · 2016 to 2025
$25.9M
BIOCHEMICAL &CHEMICAL TRAINING FOR CANCER RESEARCHT32CA009582 · NCI · VANDERBILT UNIVERSITY · PI David K Cortez · 1987 to 2026
$8.8M
Mechanism of Wnt signal transductionR35GM122516 · NIGMS · VANDERBILT UNIVERSITY · PI ETHAN LEE · 2017 to 2026
$5.8M
Genetic and Molecular Dissection of Wnt Pathway ActivationSupplementR35GM136233 · NIGMS · DARTMOUTH COLLEGE · PI Yasmath Ahmed · 2020 to 2026
$4.5M
Physical aspects of Drosophila Gastrulation - Equipment supplementR01GM134207 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Konstantin Doubrovinski · 2019 to 2026
$3.0M
The Role of Cancer-Associated Fibroblasts in Thyroid CarcinomaR01CA272875 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WEISS, VIVIAN LEE · 2022 to 2025
$2.5M
Defining signaling networks in epithelial homeostasisR35GM147128 · NIGMS · UNIVERSITY OF ARIZONA · PI Curtis Andrew Thorne · 2022 to 2026
$2.0M
Targeting Wnt-dependent colorectal cancerR01CA219189 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROBBINS, DAVID J · 2018 to 2022
$1.9M
Modulation of colonocyte barrier function and signaling by cytomegalovirus infectionR01DK137411 · NIDDK · UNIVERSITY OF ARIZONA · PI Felicia D Goodrum, Andrew Luther Paek · 2024 to 2026
$1.6M
Training in Pharmacological SciencesT32GM149363 · NIGMS · VANDERBILT UNIVERSITY · PI T M Iverson, Ege T Kavalali · 2023 to 2026
$1.2M
NCI NIH HHS F30 CA281125NCI NIH HHS K08 CA240901NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA219189NCI NIH HHS R01 CA272875NCI NIH HHS T32 CA009582NHLBI NIH HHS F31 HL177984NICHD NIH HHS R21 HD105189NIDDK NIH HHS R01 DK137411NIGMS NIH HHS P20 GM113132NIGMS NIH HHS R01 GM134207NIGMS NIH HHS R35 GM122516NIGMS NIH HHS R35 GM136233NIGMS NIH HHS R35 GM147128NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM149363NIH HHS S10 OD032310
6 · The paper itself

Abstract

β-catenin is a critical effector of the Wnt pathway and a key component of the cadherin complex. Whether Wnt-regulated cytoplasmic β-catenin interacts with the cadherin-associated pool under physiological conditions is unclear. Using a cell line depleted of N- and E-cadherins, we demonstrate that cadherin-depleted cells exhibit lower levels of basal b-catenin that plateau to a similar level as the parental line with Wnt3a stimulation. The cadherin-depleted line exhibits significantly enhanced levels of Wnt signaling by comparison to its parental control; these effects are reversed by wild-type E-cadherin but not E-cadherin with disrupted b-catenin-binding. Enhanced Wnt signaling in the cadherin-depleted line is consistent with a previous study showing that Wnt pathway activation correlates with fold changes in β-catenin levels, rather than the absolute concentration. Our mathematical modeling suggests a mechanism in which β-catenin binding to cadherins acts as a sink to maintain elevated cytoplasmic b-catenin levels in the face of b-catenin destruction complex activity, and also limits pathway response. Our bioinformatic analysis reveals a correlation between elevated Wnt target gene expression and E-cadherin loss in a Wnt-driven model of thyroid cancer. Our results have relevance for tumorigenesis, as cadherin loss is commonly associated with poor prognosis and increased metastatic potential.

Indexed as

CadherinsWnt Signaling Pathwaybeta CateninHumansProtein BindingWnt3A Proteinbeta CateninCadherinsWnt3A Protein

Identifiers

PMID41537764
PMCPMC12911851

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.